Steven Cannella, MD
Pain Medicine · Webster, TXNPI 1063465649
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.5%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 53 manufacturers reported payments, led by Stratus Medical, LLC at 49.9% of the total. Reporting peaked in 2023 at $8,520 and has fallen 93.0% since, to $596 in 2025. Among pain medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 440 payments — averaging $64.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stratus Medical, LLC$14K
- Nevro Corp.$3K
- Vertiflex, Inc.$3K
- Boston Scientific$2K
- Medtronic$834
- AbbVie$546
- plus $6K from 47 others
What the payments were for
- Consulting fees$5,75020%
- Speaking & faculty fees$8,00028%
- Travel & lodging$2,6319%
- Food & beverage$11,80142%
- Education$350%
- Entertainment$2071%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nimbus$14,126
- Superion ISS$2,260
- Senza Spinal Cord Stimulation System$1,215
- Intracept$644
- mild Device Kit$304
- SUPERION$216
- Prometra II$207
- Evoke$148
- Senza$127
- nanoLOCK$121
- INTELLIS ADAPTIVESTIM$115
How this compares
$28,423 in reported general payments places this provider in the 90th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 52 | $54,583 |
| OxycontinOxycodone Hcl | 76 | $48,098 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 854 | $21,018 |
| Morphine Sulfate ErMorphine Sulfate | 385 | $12,120 |
| Buprenorphine | 20 | $8,747 |
| Fentanyl | 74 | $6,101 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 233 | $5,748 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 61 | $1,435 |
| Hydromorphone Hcl | 111 | $1,384 |
| Tramadol Hcl ErTramadol Hcl | 21 | $1,215 |
| Oxycodone Hcl | 101 | $1,184 |
| Pregabalin | 46 | $1,073 |
| Gabapentin | 56 | $1,024 |
| Morphine Sulfate | 43 | $1,023 |
| Tramadol Hcl | 81 | $580 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $375 | $54,58352 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $54 | $9,77063 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 583 pain medicine providers in Texas.
Other pain medicine in Webster
- Eduardo GarciaWebster$147K
- Mohamad AzzamWebster$51K
- Joseph Toothaker AlvarezWebster$23K
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
- Candice BurnetteSugar Land$265K
- Ashley Bailey-ClassenFort Worth$244K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.